Melanoma
Latest News
Subset of patients with melanoma have very low mortality risk
The authors were interested in identifying lesions that are currently diagnosed as melanoma but might lack the capacity for metastasis.
Perspectives
Diagnosed too late
We take a course in giving bad news, but every doctor has his or her own approach.
Latest News
What are the risk factors for Mohs surgery–related anxiety?
“Routinely recommending consultations may not be the best approach for improving anxiety outcomes,” the study authors wrote.
Latest News
Who’s more likely to develop a second primary melanoma?
"High numbers of nevi and high genetic predisposition were more strongly associated with second [rather] than first primary melanomas."
Conference Coverage
Latinx and melanoma: Barriers and opportunities
A qualitative study in California reveals challenges and attitudes that could be addressed with new melanoma outreach and prevention strategies....
Conference Coverage
Stage 3 melanoma attacked with immunotherapy and a virus-like particle
Phase 2 trial achieves some success, and responders had infiltrate of plasmacytoid dendritic cells.
Conference Coverage
Stool transplants may boost immunotherapy success in melanoma
A phase 1 trial shows good clinical response after transplants from healthy donors.
Commentary
Discontinuing immunotherapy: Is the infusion bag half empty or half full?
Clinical trials of immunotherapy or chemoimmunotherapy have generally terminated treatment in nonprogressing patients after 2 years.
Conference Coverage
How AI is, or will soon be, relevant in radiation oncology
Radiation oncologists at ASTRO 2022 discuss practical applications of AI, and new research findings.
From the Journals
Chronic stress, especially race related, may hasten cancer death
High allostatic load was associated with an 80% increased risk of cancer death among all study participants.
From the Journals
Third COVID booster benefits cancer patients
For the first time, researchers have quantified the benefits of boosters for COVID-19 in cancer patients.